Pharmacokinetics of Bictegravir in Adults With Normal and Impaired Renal Function

Summary

The primary objective of this study is to evaluate the pharmacokinetic (PK) profile of oral bictegravir (formerly GS-9883) in adults with impaired renal function relative to matched, healthy controls with normal renal function. Each participant in the renal impairment groups will be matched for age (± 10 years), gender, and body mass index \[BMI (± 20%, 18 ≤ BMI ≤ 40 kg/m\^2)\] with a participant in the control group.

Timeline

Start

2015-04-17

Primary completion

2015-07-06

Completion

2015-07-13

Drugs

Indications